Navigation Links
Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
Date:4/26/2012

: Millions Millions Basic[(1)] 553.5 549.5 Effect of dilutive shares: Share based awards to employees[(2)] 8.6 10.9 Convertible bonds 2.75% due 2014[(3)] 33.5 33.2 Diluted 595.6 593.6

[(1)]. Excludes shares purchased by the Employee Benefit Trust and presented by Shire as treasury stock.

[(2)]. Calculated using the treasury stock method.

[(3)]. Calculated using the "if converted" method.


The share equivalents not included in the calculation of the diluted weighted average number of shares are shown below:

3 months to March 31, 2012 2011 No. of shares No. of shares Millions[(1)] Millions[(1)] Share based awards to employees 6.1 7.5

[(1)]. Certain stock options have been excluded from the calculation of diluted EPS because (a) their exercise prices exceeded Shire's average share price during the calculation period or (b) the required performance conditions were not satisfied as at the balance sheet date.


Unaudited US GAAP results for the three months to March 31, 2012

Selected Notes to the Financial Statements

(2)  Analysis of revenues

3 months to March 31, 2012 2011 2012 2012 % % of total $M $M change Revenue Net product sales: Specialty Pharmaceuticals ("SP") ADHD VYVANSE 260.0 202.3 29% 22% ADDERALL XR 111.4 111.2 0% 9% INTUNIV 68.5 41.9 63% 6% EQUASYM 7.2 4.6 57% <1% 447.1 360.0 24% 37% Gastro Intestinal ("GI") LIALDA/MEZAVANT 90.0 87.1 3% 8% PENTASA 65.8 64.5 2% 6% RESOLOR 2.4 0.9 167% <1% 158.2 152.5 4% 14% General products FOSRENOL 45.5 41.2 10% 4% XAGRID 23.2 22.7 2% 2% 68.7 63.9 8% 6% Other product sales 32.7 39.7 -18% 3% Total SP product sales 706.7 616.1 15% 60% Human Genetic Therapies ("HGT") REPLAGAL 134.4 105.4 28% 11% ELAPRASE 125.6 103.5 21% 11% VPRIV 71.7 59.0 22% 6% FIRAZYR 19.7 5.3 272% 2% Total HGT product sales 351.4 273.2 29% 30% Regenerative Medicine ("RM") DERMAGRAFT 48.8 - n/a 4% Total RM product sales 48.8 - n/a 4% Tota
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014  Depomed, Inc. (NASDAQ: DEPO ) ... year 2014 financial results after the market closes on Wednesday, ... call beginning at 4:30 pm EDT, 1:30 pm PDT to discuss ... by dialing 877-317-6789 ( United States ) ... available via a live webcast on the investor relations ...
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- ScriptPro, of ... Powers Lake, Wisconsin , announce ... distribution and co-marketing agreement allowing ScriptPro to bring ... the United States . ScriptPro ... and workflow systems to retail and ambulatory pharmacies. ...
(Date:7/25/2014)... -- CVS Caremark Corporation (NYSE: CVS ) will ... 2014, at 8:30 a.m. (EDT) with analysts and investors ... An audio webcast of the conference call will ... the CVS Caremark website for all interested parties.  To ... will be archived and available on the web site ...
Breaking Medicine Technology:Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3
... Mylan Inc. (Nasdaq: www.mylan.com . ... release includes statements that constitute "forward-looking statements." These statements ... the Private Securities Litigation Reform Act of 1995. Because ... results may differ materially from those expressed or implied ...
... 6 Endo Pharmaceuticals (Nasdaq: ENDP ) today ... Specialty Pharmaceuticals Conference on Thursday, August 12, 2010 , at 8:00 ... Endo, will review the company,s products and development programs. , ... The presentation will be webcast live and can ...
Cached Medicine Technology:Endo to Present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference 2
(Date:7/25/2014)... The Little Gym of Houston will attend the ... at Discovery Green in downtown Houston. The eleven ... Spring, The Woodlands, Sugarland-Missouri City, Kingwood, Bellaire and their ... to be attending and performing at the Family Fun ... Sugarland-Missouri City location. “We believe in the message and ...
(Date:7/25/2014)... 25, 2014 AttorneyOne.com, a recognized authority on ... from the FDA on Ibuprofen and Oxcarbazepine Tablets . ... lot of Ibuprofen and one lot of Oxcarbazepine Tablets, by ... mislabeled packaging. Oxcarbazepine is used for the treatment of certain ... The reason for the recall is that Lot #142588, Expiration ...
(Date:7/25/2014)... Ticket Down is a reliable source for cheap ... California Memorial Stadium. With the post-World Cup emotions still rolling ... the 2014 Guinness International Champions Cup have brought eight of ... representing La Liga, English Premier League, Serie A, and Superleague ... players from around the world to 12 American cities and ...
(Date:7/25/2014)... AZ (PRWEB) July 25, 2014 ... , a Nuanced Media client and the nation’s ... and dental employee handbooks, announced their partnership with ... TransAct is a registered ISO/MSP of Chase Paymentech ... the transaction processing industry. Companies that are members ...
(Date:7/25/2014)... 25, 2014 Hastings and Hastings, ... attorney’s fees with regard to personal injury claims, announces ... wide range of legal services for those that have ... another individual or corporation. Free initial consultation services gives ... of a potential personal injury claim . It ...
Breaking Medicine News(10 mins):Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:Nuanced Media Client, CEDR HR Solutions, Partners with TransAct to Serve Medical, Dental, and Eye Care Professionals 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3
... May 13 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, Inc. ... of pharmaceutical, medicinal and diagnostic products in China,today ... at 5:00 p.m. Eastern,Time on May 15, 2008 ... Joining Mr. Yan-qing Liu, Chairman, CEO and ...
... blood-pressure drugs given in the study were probably too high ... the blood pressure-lowering drugs known as beta blockers after having ... a stroke, a new Canadian study found. , However, the ... heart attack, according to the report in the May 13 ...
... 13 Paramed Systems today announced,the release and first ... fully motorized stair climbing chair to oil and,gas platform ... the MOV chair on,drilling platforms will enable the safe ... platform., Paramed developed the dual-track MOV in response ...
... Calif., May 13 TorreyPines Therapeutics, Inc.,(Nasdaq: TPTX ... first quarter ended March 31, 2008. For the three-month ... net loss of $3.9 million. Cash,and cash equivalents totaled ... been diligently executing on the strategic plan outlined in,February, ...
... Calif., May 13 Visage Imaging,Inc., a wholly ... announced it was selected by Tufts Medical Center, ... system with the fully integrated,Visage Cardiac Analysis Package. ... offering outstanding patient care, teaching,generations of future physicians ...
... platform updates and product road map for developers., ... take the next step toward increasing patient safety ... Microsoft Health Common User,Interface (CUI), available today from ... toolkit controls and showcase demonstrators,the Microsoft Health CUI ...
Cached Medicine News:Health News:China Sky One Medical, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:Beta Blockers Raise Stroke, Death Risk After Surgery 2Health News:Beta Blockers Raise Stroke, Death Risk After Surgery 3Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 2Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 3Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 4Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 5Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 6Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 7Health News:Visage Imaging to Provide Fully Integrated Thin Client-Based Solution to Tufts Medical Center 2Health News:Visage Imaging to Provide Fully Integrated Thin Client-Based Solution to Tufts Medical Center 3Health News:Updated Microsoft Health Common User Interface Furthers Clinical Effectiveness, Increases Patient Safety 2Health News:Updated Microsoft Health Common User Interface Furthers Clinical Effectiveness, Increases Patient Safety 3
The PYRAMETRIX PLUS instrument system is the next generation in design for disc space preparation and removal....
Kerrison (Spurling) Laminectomy Rongeur. 15 cm - 6, thick footplate, large handle, 90 up-cutting, 2 mm wide....
Schlesinger Laminectomie Rongeur, golden springs. 15 cm - 6, with narrow footplate, large handle, 40 down-cutting, jaws 3 mm wide....
Kerrison (Micro) Laminectomy rongeur with ejector. 18 cm - 7 1/8, thick footplate, small handle, very delicate, 40 up-cutting, jaws 2 mm wide....
Medicine Products: